Explore how etanercept, a targeted biologic therapy, offers new hope for patients with treatment-resistant psoriatic arthritis through a 26-week clinical study.
Exploring sustained remission with rituximab and etanercept combination therapy after TNF failure in rheumatoid arthritis through clinical case studies and scientific mechanisms.